Inicio › Colitis ulcerativa › Georgia
Ensayos clínicos de Colitis ulcerativa en Georgia
15 estudios sobre Colitis ulcerativa buscan participantes en Georgia.
Ciudades en Georgia
Texto oficial del estudio (inglés)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
- Gastroenterology Consultants - Roswell /ID# 281235, Roswell
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07697456A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Gastroenterology Associates of Central Georgia ( Site 1060), Macon
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Associates, Atlanta
- Children's Center for Digestive Health Care, Atlanta
- Gastroenterolgy Associates of Central GA, Macon
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
ReclutandoFase 3
Edades de 3 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06663332A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04844606A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Childrens Center For Digestive Health Care /ID# 273228, Atlanta
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07071519Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07513181A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06095128A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Digestive Healthcare of Georgia, Atlanta
- AGA GA Research LLC, Atlanta
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT06581328A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Specialists, Suwanee
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Associates - Site Number: 8400109, Atlanta
- M3 Wake Research - Atlanta - Site Number: 8400028, Sandy Springs
- EBGS Clinical Research Center, LLC - Site Number: 8400037, Snellville
- y 1 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07184996A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Center For Digestive Healthcare, Atlanta
ReclutandoFase 3
Edades de 2 en adelante · Todos los sexos · Actualizado el 7 may 2026 · NCT05442567A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400018, Marietta
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 abr 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Atlanta
- Mirador Therapeutics Selected Site, Snellville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.